Zalicus Valuation Percentage
Zalicus Valuation Percentage Chart
View Valuation Percentage for ZLCS.
Start Your YCharts Pro Gold Membership.
Zalicus Historical Valuation Percentage Data
Pro Data ExportThere is no data for the selected date range.
About Valuation Percentage
Click the "Learn More" link below to see how the valuation percentage is calculated.
The valuation percentage shows how far above or below its historical valuation levels the stock currently is. It takes into account a long-term average of the Price to Sales Ratio and Price to Earnings Ratio and mathematically determines whether the current price is high or low relative to those historic valuation multiples.
It is important to note that this is not a measurement of how the stock's price relates to its "intrinsic value", but is instead a measurement of how the market is valuing the stock relative to how it was valued historically.
Learn More
View Valuation Percentage for ZLCS.
Start Your YCharts Pro Gold Membership.
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
YCharts Pro is only $49/month, and comes with a 14-day free trial.
Get Started NowAlready a YCharts Pro Gold Member? Sign in here.
ZLCS Valuation Percentage Benchmarks
| Companies | |
|---|---|
| Amicus Therapeutics | Go Pro |
| Vical | Go Pro |
| ARCA biopharma | Go Pro |
ZLCS Valuation Percentage Rankings
| Overall |
87th percentile 986 of 8002 |
| Sector |
82nd percentile 116 of 650 in Healthcare |
| Industry |
87th percentile 29 of 237 in Biotechnology |
ZLCS Valuation Percentage Range, Past 5 Years
| Minimum | Go Pro | Sep 2012 |
| Maximum | Go Pro | Sep 2008 |
| Average | Go Pro |